Status:
UNKNOWN
Intraoperative Detection of Residual BCC by Fast Raman
Lead Sponsor:
University of Nottingham
Collaborating Sponsors:
Nottingham University Hospitals NHS Trust
Circle Nottingham NHS Treatment Centre
Conditions:
Carcinoma, Basal Cell
Intraoperative BCC Detection by Fast Raman Device
Eligibility:
All Genders
Brief Summary
The main objective of this research is to develop a new scanning technology called the Fast Raman device, to accurately check the skin removed by the surgeon and detect any residual cancer cells; if f...
Detailed Description
Raman spectroscopy (RS) is an established analytical technique and has been extensively used in medicine to study individual cells and complex tissues, including skin and skin cancers. This technique ...
Eligibility Criteria
Inclusion
- Patients undergoing Mohs micrographic surgery of BCC.
- Able to give informed consent.
- Any age.
Exclusion
- Patients where there is any doubt regarding the diagnosis from pathologist as ascertained by previous diagnostic biopsy.
Key Trial Info
Start Date :
April 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2023
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT03482622
Start Date
April 1 2018
End Date
March 31 2023
Last Update
March 29 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.